饲料添加剂红法夫酵母
Search documents
金河生物:公司已建成年产3000吨虾青素项目,相关产品饲料添加剂红法夫酵母已获得产品批准文号
Mei Ri Jing Ji Xin Wen· 2026-01-07 01:11
每经AI快讯,有投资者在投资者互动平台提问:请问贵司生产的虾青素是否已经量产并销售?已经量 产上市销售,请问2025年虾青素销售营业额占总营业额的多少?预计2026年能到多少占比? 金河生物(002688.SZ)1月7日在投资者互动平台表示,公司已建成年产3000吨虾青素项目,相关产品 饲料添加剂红法夫酵母已获得产品批准文号,目前正处于市场推广中。具体经营情况届时请关注公司披 露的相关公告。 (记者 王晓波) ...
金河生物:公司已建成年产3000吨虾青素项目 相关产品饲料添加剂红法夫酵母正处于市场推广中
Mei Ri Jing Ji Xin Wen· 2025-11-24 06:40
Core Viewpoint - The company, Jinhe Biology, has developed astaxanthin products with strong antioxidant capabilities, applicable in various fields such as health food, aquaculture, feed, pharmaceuticals, and cosmetics [2]. Group 1: Product Application and Market Response - Astaxanthin products can be utilized in health food, aquaculture, feed, pharmaceuticals, and cosmetics due to their strong antioxidant properties [2]. - The company has initiated a strategic partnership with Shanghai Jiao Tong University School of Life Sciences and Technology to develop its first synthetic biology product, astaxanthin [2]. - The astaxanthin produced is a metabolite from red yeast during fermentation, which has a similar left-handed structure to naturally extracted astaxanthin from red algae, but with higher yield and lower cost compared to natural extraction methods [2]. Group 2: Production Capacity and Market Promotion - The company has established an annual production capacity of 3,000 tons for astaxanthin [2]. - The feed additive product derived from red yeast has received product approval and is currently in the market promotion phase [2].
金河生物:公司已建成年产3000吨虾青素项目,相关产品饲料添加剂红法夫酵母正处于市场推广中
Mei Ri Jing Ji Xin Wen· 2025-11-24 01:05
Core Viewpoint - The company has developed astaxanthin products with strong antioxidant capabilities, applicable in various fields such as health food, aquaculture, feed, pharmaceuticals, and cosmetics [2]. Group 1: Product Applications - Astaxanthin can be utilized in health food, aquaculture, feed, pharmaceuticals, and cosmetics due to its strong antioxidant properties [2]. - The company's astaxanthin product is the first synthetic biology product developed in collaboration with Shanghai Jiao Tong University [2]. Group 2: Production and Market Status - The company has established an annual production capacity of 3,000 tons of astaxanthin [2]. - The feed additive derived from red yeast has received product approval and is currently in the market promotion phase [2].
金河生物(002688.SZ):目前已建成年产3000吨虾青素项目
Ge Long Hui· 2025-11-24 01:01
Core Viewpoint - The company, Jinhe Biology, is leveraging its astaxanthin product, which has strong antioxidant properties, for applications in health food, aquaculture, feed, pharmaceuticals, and cosmetics [1] Group 1: Product Development - The astaxanthin product is the first synthetic biology product developed in collaboration with Shanghai Jiao Tong University School of Life Sciences [1] - The product is a metabolic byproduct of red yeast during fermentation, with a structure similar to natural astaxanthin extracted from red algae [1] - The synthetic method offers higher yield and lower cost compared to natural extraction methods [1] Group 2: Production Capacity - The company has established an annual production capacity of 3,000 tons for astaxanthin [1] - The feed additive product derived from red yeast has received product approval and is currently in the market promotion phase [1]
金河生物:虾青素产品落地 合成生物学产业应用见成效
Zheng Quan Ri Bao· 2025-11-04 05:12
Core Points - Jinhe Biological Technology Co., Ltd. has received approval for its feed additive product, red yeast, from the Inner Mongolia Agricultural and Animal Husbandry Department [2][3] - Astaxanthin, a carotenoid with strong antioxidant properties, has significant application potential in health foods, aquaculture, pharmaceuticals, and cosmetics [2] - The company has established an annual production capacity of 3,000 tons of astaxanthin, indicating its commitment to research and innovation in synthetic biology applications [3] Summary by Category - **Product Approval** - Jinhe Biological has obtained the product approval number for its feed additive, red yeast, enhancing its product portfolio [2][3] - **Astaxanthin Properties** - Astaxanthin is noted for its antioxidant capacity, being 10 times more potent than beta-carotene, 200 times more than lutein, and 550 times more than vitamin E [2] - The main sources of astaxanthin include natural extraction, chemical synthesis, and microbial fermentation, with fermentation being the most viable method due to safety and stability [2] - **Commercial Value** - Red yeast is recognized for its rapid growth cycle, short fermentation period, ease of cultivation, and ability to utilize various carbon sources, making it commercially valuable [2] - The approval of the red yeast product is expected to enhance Jinhe Biological's operational performance and market competitiveness [3]
金河生物:虾青素产品落地,合成生物学产业应用见成效
Zheng Quan Shi Bao Wang· 2025-11-04 04:02
Core Viewpoint - The company has received approval for its feed additive product, red yeast, which is expected to enhance its product portfolio and market competitiveness, driven by the increasing demand for natural astaxanthin in various industries [2][3]. Group 1: Product Approval and Market Potential - The company has obtained the product approval number for its feed additive, red yeast, from the Inner Mongolia Agricultural and Animal Husbandry Department [2]. - Astaxanthin, a carotenoid with strong antioxidant properties, has a market value of $3.7 billion in 2022 and is projected to reach $11 billion by 2032 [2]. - The company has a production project with an annual capacity of 3,000 tons of astaxanthin, indicating significant production capabilities [2]. Group 2: Advantages of Red Yeast - Red yeast is recognized for its rapid growth cycle, short fermentation period, ease of cultivation, and ability to utilize various carbon sources, making it commercially valuable [3]. - The approval of the red yeast feed additive is expected to enrich the company's product structure and positively impact its operational performance and market competitiveness [3].
金河生物:关于获得饲料添加剂产品批准文号的公告
Zheng Quan Ri Bao· 2025-11-03 11:11
Core Viewpoint - Jinhe Biological has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Agricultural and Animal Husbandry Department [2] Group 1 - The company announced on the evening of November 3 that it has obtained the product approval number for its feed additive [2] - The approval signifies a regulatory milestone for the company's product development in the feed additive sector [2]
金河生物:饲料添加剂红法夫酵母获产品批准文号
Zhi Tong Cai Jing· 2025-11-03 07:55
Core Viewpoint - The company Jinhe Biotechnology (002688.SZ) has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Department of Agriculture and Animal Husbandry [1] Group 1 - The company has developed a feed additive called red yeast, which has now been granted a product approval number [1]
金河生物(002688.SZ):饲料添加剂红法夫酵母获产品批准文号
智通财经网· 2025-11-03 07:49
Core Viewpoint - The company Jinhe Biotechnology (002688.SZ) has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Department of Agriculture and Animal Husbandry [1] Group 1 - The company has been granted the product approval number for its developed feed additive, red yeast [1]
金河生物:开发的饲料添加剂红法夫酵母获产品批准文号
Xin Lang Cai Jing· 2025-11-03 07:48
Core Viewpoint - The company has received approval for its feed additive product, red yeast, which is expected to enhance its product portfolio and competitiveness, although it is not anticipated to have a significant impact on this year's performance [1] Group 1: Product Approval - The company has obtained the product approval number for its feed additive red yeast from the Inner Mongolia Agricultural and Animal Husbandry Department, with the approval date set for September 15, 2025 [1] - The approval number is 蒙饲添字(2025)090001, indicating regulatory compliance for the new product [1] Group 2: Production Capacity - The company has established a production project with an annual capacity of 3,000 tons for astaxanthin, a metabolite of red yeast [1] - This production capacity is expected to support the company's growth and diversification in its product offerings [1] Group 3: Financial Impact - The approval of the new product is expected to enrich the company's product structure and enhance its competitiveness [1] - However, it is noted that the approval will not have a major impact on the company's performance for the current fiscal year [1]